April 6 (Reuters) - Admedus Ltd AHZ.AX :
* ANNOUNCES US FDA CLEARANCE OF AN INDICATION CHANGE TO ITS ADAPT-TREATED (BOVINE PERICARDIUM) TISSUE THROUGH SPECIAL 510(K) PATHWAY
April 6 (Reuters) - Admedus Ltd AHZ.AX :
* ANNOUNCES US FDA CLEARANCE OF AN INDICATION CHANGE TO ITS ADAPT-TREATED (BOVINE PERICARDIUM) TISSUE THROUGH SPECIAL 510(K) PATHWAY